Combined, the in vitro and in vivo evidence in this study elucidates critical functions of OTUD1 in the termination of TGF-β/SMAD-induced metastatic activation, indicating that OTUD1 restricts the EMT and cancer stem cell traits during metastasis. The gene discussed is TGFB1; the disease is cancer.